Welcome to Coulter Partners Global (English)

15 April 2025

Top hires for VC & PE portfolio companies Q1-2025

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Exosome technologies Italy
CEO CRO France
CEO Cell & gene therapy tools UK
Chief Development Officer Cell reprogramming Sweden
Chief Financial Officer Antibody-drug conjugates Germany/ US
Chief Business Officer Small molecule therapeutics Switzerland/ US
Chief Scientific Officer AI platform technologies UK
Chief Commercial Officer CDMO UK
Chief Technology & Operations Officer Precision fermentation Sweden
Chief R&D Officer Mitochondrial medicine UK
VP, Head of Biometrics Oncology drug development US
VP, CMC & Development T-cell technologies UK
Head of Regulatory Small molecule inhibitors US
Global Marketing Director Biosurgery Surgical technologies US
General Manager France Remote patient monitoring UK/ France
Head of Hospitals & Value Access Ophthalmology therapeutics Italy
Senior Executive Director, Translational Radiopharmaceuticals US
Senior Director, New Ventures and Investments University incubator/ accelerator Australia

Newly opened projects include:

Function Focus area Location
CEO Bio-storage solutions UK
Chief Financial Officer Cardiac devices France
Chief Scientific Officer tRNA platform US
Chief Operating Officer Medical devices UK
Chief Business Officer AI-enabled imaging Spain
Chief Scientific Officer Neuropsychiatry US
Head of Sales and Marketing Specialty pharma UK
Country CEO Healthcare services France
International Commercial Director Specialty pharma UK
Board Director Oncology pharma Australia
Board Director Antibody platform Canada
Chair Healthtech Belgium
Fund Managing Partner Life sciences research institution UK

Related

A new version of Coulter Partners is available.